NOT KNOWN DETAILS ABOUT FENTANYL DETECTION MACHINE

Coadministration of pexidartinib (a CYP3A4 inducer) with sensitive CYP3A substrates may produce critical therapeutic failures. If concomitant use is unavoidable, improve the CYP3A substrate dosage in accordance with authorised product labeling.Concomitant utilization of fentanyl injection with CYP3A4 inducers or discontinuation of the CYP3A4 inhibi